We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News   Aug 17, 2018 | Original story from the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP)

 
Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

Signal receptor-containing vesicles (red) form on the inside of the cell membrane (brown) and bud off into the cell. The magnifying glass shows molecular details of the active lipid kinase PI3KC2A. Credit: Thomas Splettstoesser

 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Additional Evidence Shows HPV Vaccine is Safe

News

Further evidence has been generated to demonstrate the safety of the life-saving bivalent HPV vaccine.

READ MORE

T Cell Study Uncovers New Hurdle for Developing Immunotherapies

News

There's an unexpected challenge to be overcome - T cell receptors can be more cross-reactive than previously thought.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE